UK markets open in 40 minutes

iShares $ Corp Bond ETF USD Dist (LQDA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.55-0.40 (-3.09%)
At close: 04:00PM EDT
12.36 -0.19 (-1.51%)
After hours: 07:42PM EDT

iShares $ Corp Bond ETF USD Dist

419 Davis Drive
Suite 100
Morrisville, NC 27560
United States
919 328 4400
https://www.liquidia.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees145

Key executives

NameTitlePayExercisedYear born
Dr. Roger A. Jeffs Ph.D.CEO & Director532.23kN/A1962
Mr. Michael KasetaCOO & CFO627.85kN/A1977
Mr. Russell SchundlerGeneral Counsel & Corporate Secretary541.92kN/A1975
Mr. William R. Kenan Jr.Co-FounderN/AN/AN/A
Dr. Ginger DenisonCo-FounderN/AN/AN/A
Jennifer AlmondDirector of Investor Relations & Corporate CommunicationsN/AN/AN/A
Ms. Sarah Krepp SPHRVice President of People & CultureN/AN/AN/A
Mr. Jason AdairChief Business OfficerN/AN/A1974
Dr. Tushar Shah M.D.Senior Vice President of Product Development792.36kN/A1961
Mr. Scott MoomawChief Commercial OfficerN/AN/A1971
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Corporate governance

iShares $ Corp Bond ETF USD Dist’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.